PMID- 35949362
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220813
IS  - 2752-5457 (Electronic)
IS  - 2752-5457 (Linking)
VI  - 18
IP  - 1
DP  - 2022 Jun
TI  - Utilizing the New Glucometrics: A Practical Guide to Ambulatory Glucose Profile 
      Interpretation.
PG  - 20-26
LID - 10.17925/EE.2022.18.1.20 [doi]
AB  - Traditional continuous glucose monitoring and flash glucose monitoring systems 
      are proven to lower glycated haemoglobin levels, decrease the time and impact of 
      hypoglycaemia or hyperglycaemia and, consequently, improve the quality of life 
      for children and adults with type 1 diabetes mellitus (T1DM) and adults with type 
      2 diabetes mellitus (T2DM). These glucose-sensing devices can generate large 
      amounts of glucose data that can be used to define a detailed glycaemic profile 
      for each user, which can be compared with targets for glucose control set by an 
      International Consensus Panel of diabetes experts. Targets have been agreed upon 
      for adults, children and adolescents with T1DM and adults with T2DM; separate 
      targets have been agreed upon for older adults with diabetes, who are at higher 
      risk of hypoglycaemia, and women with pregestational T1DM during pregnancy. Along 
      with the objective measures and targets identified by the International Consensus 
      Panel, the dense glucose data delivered by traditional continuous glucose 
      monitoring and flash glucose monitoring systems is used to generate an ambulatory 
      glucose profile, which summarizes the data in a visually impactful format that 
      can be used to identify patterns and trends in daily glucose control, including 
      those that raise clinical concerns. In this article, we provide a practical guide 
      on how to interpret these new glucometrics using a straightforward algorithm, and 
      clear visual examples that demystify the process of reviewing the glycaemic 
      health of people with T1DM or T2DM such that forward-looking goals for diabetes 
      management can be agreed.
CI  - (c) Touch Medical Media 2022.
FAU - Doupis, John
AU  - Doupis J
AD  - Department of Internal Medicine and Diabetes, Salamis Naval and Veterans 
      Hospital, Salamis, Attiki, Greece.
AD  - Iatriko Paleou Falirou Medical Center, Diabetes Clinic, Athens, Greece.
FAU - Horton, Edward S
AU  - Horton ES
AD  - Harvard Medical School, Boston, MA, USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220613
PL  - England
TA  - touchREV Endocrinol
JT  - TouchREVIEWS in endocrinology
JID - 101779126
PMC - PMC9354515
OTO - NOTNLM
OT  - Ambulatory glucose profile
OT  - continuous glucose monitoring
OT  - glycaemic variability
OT  - hypoglycaemia
OT  - time below range
OT  - time in range
OT  - type 1 diabetes mellitus
OT  - type 2 diabetes mellitus
COIS- Disclosures: John Doupis has received honoraria for lectures and consulting fees 
      from Abbott. Edward S Horton has no financial or non-financial relationships or 
      activities to declare in relation to this article.
EDAT- 2022/08/12 06:00
MHDA- 2022/08/12 06:01
PMCR- 2022/06/01
CRDT- 2022/08/11 02:15
PHST- 2022/03/21 00:00 [received]
PHST- 2022/05/03 00:00 [accepted]
PHST- 2022/08/11 02:15 [entrez]
PHST- 2022/08/12 06:00 [pubmed]
PHST- 2022/08/12 06:01 [medline]
PHST- 2022/06/01 00:00 [pmc-release]
AID - 10.17925/EE.2022.18.1.20 [doi]
PST - ppublish
SO  - touchREV Endocrinol. 2022 Jun;18(1):20-26. doi: 10.17925/EE.2022.18.1.20. Epub 
      2022 Jun 13.